Annexon Biosciences Stock

Biotechnology company developing therapeutics for neurodegenerative and autoimmune disorders

About Annexon Biosciences Stock

Annexon Biosciences is the development of therapeutic products that halt the progression of complement-mediated neurodegeneration (CMND).

Funding History

August 2011	$1000K
December 2014	$34.0M
June 2016	$44.0M
December 2018	$75.0M

Management

Chief Scientific Officer

Ted Yednock

Co-Founder

Arnon Rosenthal

President & Chief Executive Officer

Douglas Love

Other Companies

Learn More

DNA Script

DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology.

$21.7MTotal Funding

Learn More

Tempus

Cancer battling operating system

$520MTotal Funding

Learn More

Vital

Modern cloud-based Emergency Department SaaS

$6.2MTotal Funding

Learn More

Zebra Medical Vision Ltd

Zebra Medical Vision has set out to create the world's largest medical imaging insights platform.

$20.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Annexon Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.